• Explore /
  • Poster
  • / OLIGOPELVIS – GETUG P07, a multicentre phase II trial of combined salvage radiotherapy and hormone therapy in oligometastatic pelvic node relapses of prostate cancer: Preplanned analysis of acute toxicity.

OLIGOPELVIS – GETUG P07, a multicentre phase II trial of combined salvage radiotherapy and hormone therapy in oligometastatic pelvic node relapses of prostate cancer: Preplanned analysis of acute toxicity.

Abstract Poster

Authors

null

Stephane Supiot

Institut de Cancérologie de l'Ouest - René Gauducheau, Nantes, France

Stephane Supiot , Gilles Crehange , Xavier Buthaud , David Pasquier , Ali Hasbini , Guy De Laroche , Pascal Pommier , Genevieve Loos , Veronique Beckendorf , Paul Sargos , Emmanuel Rio , Loic Campion

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Advanced Disease

Clinical Trial Registration Number

NCT02274779

Citation

J Clin Oncol 34, 2016 (suppl 2S; abstr 173)

DOI

10.1200/jco.2016.34.2_suppl.173

Abstract #

173

Poster Bd #

G8

Abstract Disclosures

Similar Posters

First Author: Stephane Supiot

First Author: Stephane Gilles Guerif

First Author: Nicholas George Nickols

First Author: Daniel Keizman